| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9959628 | Journal of the American College of Cardiology | 2005 | 6 Pages |
Abstract
Many patients who are prescribed low-dose EC aspirin for secondary prevention of cardiovascular events have persistent uninhibited platelet COX activity. Younger and heavier patients and those with a previous MI are most likely to have an inadequate response to treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Andrew O. MSc, MD, Ronan J. MSc, MD, Michelle BSc, Ronan M. BA, DSc, Peter (FRCPI), Dermot BSc, PhD, Desmond J. (FRCPI),